Richard French
Internal Medicine · Hastings, NENPI 1003819699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 285 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,666 and has fallen 99.1% since, to $15 in 2024. Among internal medicine clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 285 payments — averaging $13.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$588
- AbbVie$535
- Novo Nordisk$390
- Amgen$352
- Lilly USA, LLC$283
- Pfizer$248
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,869100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $588 |
| AbbVie(2 entities) | 41 | $535 |
| Novo Nordisk | 28 | $390 |
| Amgen | 25 | $352 |
| Lilly USA, LLC | 28 | $283 |
| Pfizer | 42 | $248 |
| Boehringer Ingelheim | 22 | $243 |
| Johnson & Johnson | 11 | $202 |
| Sanofi-aventis U.S. LLC | 15 | $198 |
| GSK | 19 | $152 |
| Novartis | 8 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $96 |
| Mylan Specialty L.p. | 5 | $70 |
| Astellas Pharma US Inc | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Eisai Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $29 |
| Merck | 2 | $29 |
| Bayer | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Insulet Corporation | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Baxter Healthcare | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Grifols USA, LLC | 1 | $11 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$558
- SYMBICORT$431
- BREZTRI AEROSPHERE$237
- BYDUREON$194
- BREZTRI$128
How this compares
$3,883 in reported general payments places this provider in the 90th percentile of 570 internal medicine providers in Nebraska.
Other internal medicine in Hastings
- Justin WenburgHastings$10K
- Paul WibbelsHastings$9K
- Douglas HentzenHastings$9K
- Matthew StrittHastings$6K
- Michelle SeizysHastings$5K
- Brian BoerOmaha$142K
- Sherri ThomasLincoln$136K
- Adam BurdorfOmaha$29K
- David SharpOmaha$26K
- David ShinOmaha$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.